FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085466 [Registered on: 23/04/2025] Trial Registered Prospectively
Last Modified On: 23/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect Of Pippalyadi Churna in Female Infertility. 
Scientific Title of Study   Randomized Controlled Clinical Trial To Study The Effect Of Pippalyadi Churna In Stree Vandhyatva With Special Reference To Anovulatory Cycle 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shafaq Zahra Ansari 
Designation  PG Scholar 
Affiliation  LRP Ayurvedic Medical College and Hospital PG Institute and Research Center Urun Islampur 
Address  OPD NO 5 Prasutitantra and Streeroga Department LRP Ayurvedic Medical College and Hospital PG Institute and Research Center Urun Islampur Sangli

Sangli
MAHARASHTRA
415409
India 
Phone  9579842780  
Fax    
Email  shafaqzahra0808@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Hemalata Chandrashekhar Kongi 
Designation  HOD  
Affiliation  LRP Ayurvedic Medical College and Hospital PG Institute and Research Center Urun Islampur 
Address  OPD NO 5 Prasutitantra and Streeroga Department LRP Ayurvedic Medical College and Hospital PG Institute and Research Center Urun Islampur Sangli

Sangli
MAHARASHTRA
415409
India 
Phone  9225347295  
Fax    
Email  drkongihema@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Hemalata Chandrashekhar Kongi 
Designation  HOD  
Affiliation  LRP Ayurvedic Medical College and Hospital PG Institute and Research Center Urun Islampur 
Address  OPD NO 5 Prasutitantra and Streeroga Department LRP Ayurvedic Medical College and Hospital PG Institute and Research Center Urun Islampur Sangli

Sangli
MAHARASHTRA
415409
India 
Phone  9225347295  
Fax    
Email  drkongihema@gmail.com  
 
Source of Monetary or Material Support  
Loknete Rajarambapu Patil Ayurvedic Medical college Hospital Post Graduate Institute and Research Center Islampur 415409 
 
Primary Sponsor  
Name  Shafaq Zahra Ansari 
Address  OPD NO 5 Prasutitantra and Streeroga Department LRP Ayurvedic Medical college Hospital Post Graduate Institute and Research Center Islampur Tl Walwa District Sangli Maharashtra India 415409 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shafaq Zahra Ansari  LRP Ayurvedic Medical college Hospital Post Graduate Institute and Research Center Islampur   OPD no 5 Prasutitantra and Streeroga Department LRP Ayurvedic Medical college and Hospital Post Graduate Institute and Research Center Islampur 415409
Sangli
MAHARASHTRA 
09579842780

shafaqzahra0808@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical Committee LRP Ayurvedic Medical college and Hospital and PCT and RC Approved   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N00-N99||Diseases of the genitourinary system. Ayurveda Condition: VANDHYA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Pippalyadi Churna, Reference: Bharat Bhaiyshajya Ratnakar, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -ghrita), Additional Information: -14 days from 5th to 18th day of Menses for 2 consecutive cycles.
2Comparator ArmDrugClassical(1) Medicine Name: Shatapushpa churna, Reference: Kashyap Samhita, Kalpasthan, Ch 5/17,18, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -Ghrita), Additional Information: -14 days from 5th to 18th day of menses for 3 consecutive cycles.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  1 Diagnosed married female patients fulfilling criteria of Stree Vandhyatva of age group 18 to 35 years.
2 Patients having regular mensturation.
3 Patients having complaints of failure to conceive due to Anovulatory cycle.
4 Primary and secondary type of infertile patient will be taken for study 
 
ExclusionCriteria 
Details  1 Patients having physiological anovulatory conditions like pregnancy lactation and menopause.
2 Patients suffering from known chronic illness, cardiac disease and known case of thyroidism.
3 Patients having Abnormal Uterine Bleeding, cervical tumor, polyp cancer of cervix, uterine fibroid.
4 Known case of congenital anomalies of female genital organ like infantile uterus and absence of ovaries. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To Study Effect Of Pipplyadi Churna in Stree Vandhyatva with special refference to Anovulatory Cycle  14 days from Day 5th to Day 18th of Menses for 2 consecutive cycles  
 
Secondary Outcome  
Outcome  TimePoints 
1. To study Stree Vandhyatva according to Ayurveda.
2. To study female Infertility with special reference to Anovulation in detail
according to modern science.
3. To study Pippalyadi Churna in detail. 
18 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   05/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Anovulation or inability to produce a fertile ovum is an important reason among woman facing infertility and still it is a growing problem due to changing life style, faulty food habits, environment, stress provoking jobs. In such patients ovulation induction is a rescuer. Over the past few decades modern medical field developed modalities like Clomid Therapy, Letrozole, Insulin sensitizing drugs, Ovarian drilling, HCG injections, Gonadotropin therapy but all these modalities are associated with many complications like Ovarian Hyperstimulation Syndrome (OHSS), Multiple Pregnancy etc. Considering all these drawbacks an appropriate management of anovulation is required. In Ayurveda, Anovulation is quoted as the result of vitiation of doshas in reproductive system of a woman suffering from menstrual disorders. Vata dosha is controller of any type of movement in the body and regeneration and growth are facilitated by Kapha. Lower part of the body is seat of Vata. When Vata is vitiated by its aggravating factors or vitiated due to the occlusion or obstruction by Kapha it cannot govern its normal functions and anovulation state persists. Among the three doshas, Vata plays major role in physiology and pathology of reproductive tract and the drug which is fruitful in Agnimandhya i.e deepana & pachana may also be useful for anovulation. Anovulation is mainly related to Rasavaha and Artavaha strotas, according to Samprapti of Nastabeej there is a sanga type of strotodusti due to dosha dushya sammurchhana. Pippalayadi Churna has mainly ushna virya which remove strotorodha and increase the secretion of endometrial glands by opening the vessels, Keeping this hypothesis in mind it is planned to evaluate the effect of Pippalyadi Churna in Anovulatory factor of infertility. 
Close